Mz. Ratajczak et al., IN-VITRO SENSITIVITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS TO 4-HYDROPEROXYCYCLOPHOSPHAMIDE, Experimental hematology, 21(13), 1993, pp. 1663-1667
Protracted engraftment and prolonged thrombocytopenia remain problems
when marrow purged with 4-hydroperoxycyclophosphamide (4-HC) is employ
ed for autotransplants. Toxic effects of 4-HC on early progenitor and
stem cells might play an important causative role. Surprisingly, few i
nvestigations have examined the effects of 4-HC on progenitor cells ot
her than colony-forming units-granulecyte/macrophage (CFU-GM) and burs
t-forming units-erythroid (BFU-E), and only one study could be found w
here 4-HC exposure was carried out on cells purified beyond the buffy
coat stage. Since the cellular milieu, and in particular the red blood
cell count, can ameliorate 4-HC toxicity, the suppressive effect of t
his agent on marrow stem cells might be underestimated. We therefore i
nvestigated the relative 4-HC sensitivity of different human bone marr
ow progenitor cells in vitro using partially purified adherent cell- a
nd T lymphocyte-depleted bone marrow mononuclear cells (A(-)T(-)MNC).
Cells were exposed to increasing doses (10 to 200 mu g/mL) of 4-HC usi
ng a standard purging protocol established for bone marrow buffy coat
cells. Effects on mixed (CFU-Mix), erythroid (CFU-E and BFU-E), granul
ocyte-macrophage (CFU-GM), and stromal cell (CFU-F) progenitors were d
etermined. In addition, we examined the 4-HC sensitivity of megakaryoc
yte progenitors (CPU-Meg) since, to our knowledge, this has not been r
eported before. As expected, increasing doses of 4-HC led to progressi
ve inhibition of hematopoietic colony formation. CFU-F, CPU-Mix, and C
FU-Meg appeared most resistant to 4-HC exposure, while CFU-E, BFU-E, a
nd CFU-GM appeared most sensitive. At doses over 100 mu g/mL, the usua
l concentration recommended. for purging of buffy coat cells, hematopo
ietic colony formation was completely inhibited. These data suggest th
at if more highly purified marrow cells are employed for purging, lowe
r 4-HC doses may need to be used. They also suggest that the thrombocy
topenia that frequently accompanies 4-HC purging is not likely due to
loss of CPU-Meg.